Author

Thomas Knösel

Primary ORCID profile (0000-0002-1822-0197 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Thomas KnöseliD2 papers · Pathologisches Institut

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Annelore Altendorf-Hofmann· 1 shared Elfriede Noessner· 1 shared Eric Kampmann· 1 shared Fabienne S. Wehweck· 1 shared Florencia Cidre-AranaziD· 1 shared Lars Lindner· 1 shared Laura Romero-PéreziD· 1 shared Marion Subklewe· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Annelore Altendorf-Hofmann

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMar 8, 2019

Expression patterns of PD-L1 and PD-1 provide rationales for immune checkpoint inhibition in soft tissue sarcomas

Martin F. Orth, Veit L. Buecklein, Eric Kampmann…·Thomas Knösel

This study examines PD-L1 and PD-1 expression in soft tissue sarcomas and finds associations with TILs and poor clinical outcomes, supporting immune checkpoint inhibition in PD-L1-positive cases.

DOI 10.1101/569418

humanbulk RNA-seq

𝕏 PostBluesky